Who are 2A Biosciences's investors?

2A Biosciences's investors include LIONHEART VENTURES.

How much funding has 2A Biosciences raised?

2A Biosciences has disclosed $3.8M raised across 1 round.

Where is 2A Biosciences headquartered?

2A Biosciences is headquartered in Santa Monica, US.

2A Biosciences

Santa Monica, US · Founded 2023 · 10 employees on LinkedIn · 1 known investors

Find your way into 2A Biosciences

159 people in our graph share verified history with the 2A Biosciences team — schools, employers, funds. One of them is your warm intro.

Jennifer Zimmermanunlockedknows Alex Speiser · together at Wesleyan University

×6knows the team · via Wesleyan University

×5knows the team · via Horace Mann School

2AB BioscienceS develops first-in-class small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders. The platform uses structure-guided design to create therapies aimed at tissue regeneration, inflammation resolution, and neural circuit restoration.

Biotech Deep Tech Digital Health Medical Devices

Founders & leadership

2A Biosciences was founded in 2023 by Alex Speiser, Charles Nichols, PhD, David Nichols, PhD, and Tim Foster, PhD.

Alex Speiser inCo-Founder & Chief Executive OfficerAlex Speiser holds a B.A. from Wesleyan University and has served as Director of Corporate Development at Eleusis and VP of Business Development at G.S. Power Partners. He is co-founder and CEO of 2A Biosciences, which develops small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders.

Charles Nichols, PhDCo-Founder & Chief Science Officer

David Nichols, PhDCo-Founder & Head of Chemistry

Tim Foster, PhDCo-Founder & Head of Translational Discovery

Board

Gopal DasBoard director

Investors · 1

LIONHEART VENTURESSan Francisco

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 1 round · 2023

▶$3.8MraisedJul 2023 · 13 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Gopal DasDirector
Alexander SpeiserExecutive Officer, Director
Charles David NicholsExecutive Officer, Director
Timothy Paul FosterDirector, Executive Officer
David Earl NicholsExecutive Officer, Director

Offering amount: $5.5M
Amount sold: $3.8M
First sale: Mar 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

2A Biosciences - BIO International Convention 2026convention.bio.org

Frequently asked questions

What does 2A Biosciences do?: 2AB BioscienceS develops first-in-class small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders. The platform uses structure-guided design to create therapies aimed at tissue regeneration, inflammation resolution, and neural circuit restoration.
Who founded 2A Biosciences?: 2A Biosciences was founded by Alex Speiser, Charles Nichols, PhD, David Nichols, PhD, Tim Foster, PhD in 2023.
Who are 2A Biosciences's investors?: 2A Biosciences's investors include LIONHEART VENTURES.
How much funding has 2A Biosciences raised?: 2A Biosciences has disclosed $3.8M raised across 1 round.
Where is 2A Biosciences headquartered?: 2A Biosciences is headquartered in Santa Monica, US.